Recombinant Human Podocin/NPHS2 Protein, CF Summary
Product Specifications
Lys259-Leu383, with an N-terminal Met and a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
9287-PO
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 200 μg/mL in PBS. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: Podocin/NPHS2
Podocin, encoded by the NPHS2 gene, is an approximately 50 kDa membrane protein that plays an important role in podocyte function in the kidney. Loss of Podocin function results in albuminuria, hypercholesterolemia, hypertension, and renal failure (1). Human Podocin consists of a 102 amino acid (aa) cytoplasmic domain, a 21 aa intramembrane segment, and a second 262 aa cytoplasmic domain (2, 3). Alternative splicing generates a short isoform with a 68 aa deletion in the second cytoplasmic domain (4, 5). Within aa 259-383 (the region common to both isoforms), human Podocin shares 90% aa sequence identity with mouse and rat Podocin. Podicin localizes to areas of cell-cell contact between podocytes in the renal glomerulus (2, 6, 7). It associates into oligomers and forms complexes with Nephrin, CAR, ZO-1, and the cation ion channel TRPC6 (6-9). It contributes to podocyte function by regulating the activation of TRPC6 and Nephrin mediated signaling (8, 9). Multiple polymorphisms in NPHS2 are associated with steroid-resistant nephrotic syndrome (2).
- Mollet, G. et al. (2009) J. Am. Soc. Nephrol. 20:2181.
- Boute, N. et al. (2000) Nat. Genet. 24:349.
- Roselli, S. et al. (2002) Am. J. Pathol. 160:131.
- Volker, L.A. et al. (2013) BMC Nephrol. 14:102.
- Relle, M. et al. (2011) Mod. Pathol. 24:1101.
- Shono, A. et al. (2007) J. Am. Soc. Nephrol. 18:2525.
- Schwarz, K. et al. (2001) J. Clin. Invest. 108:1621.
- Huber, T.B. et al. (2001) J. Biol. Chem. 276:41543.
- Anderson, M. et al. (2013) Am. J. Physiol. Cell Physiol. 305:C276.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Podocin/NPHS2 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Podocin/NPHS2 Protein, CF and earn rewards!
Have you used Recombinant Human Podocin/NPHS2 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
